Aug 14

Help Us Protect Access to Sexual and Reproductive Health Care Today!
Using medication for an abortion is safe, effective, and the preferred option for abortion care by many. During the COVID-19 pandemic, medication has offered an opportunity to end a pregnancy in the safety of one’s own home rather than risking entering a clinic for a procedure. However, this medication is not new. Mifepristone combined with…
September 28th is the 20th birthday of mifepristone, the pill commonly used for medication abortion and early pregnancy loss care. Join us this month on social media (Facebook, Instagram, Twitter) in celebrating mifepristone and recognizing the gaps to access and equity that persist. Every day through September 28th we’ll share clinician stories, resources, and actions…
September 2020 September 28th is the 20th birthday of mifepristone, the pill commonly used for medication abortion and early pregnancy loss care! For 20 years, mifepristone has helped people in the United States achieve their rights to bodily autonomy and to decide if and when to have children. And, more recently, it has supported pregnant…
As part of RHAP’s ongoing commitment to anti-racism, we wanted to share with you ways to learn with us about the history of injustice in reproductive health and how reproductive justice has become a vital part of reproductive equity. The term reproductive justice was developed by Black women in 1994, addressing the need for a movement that…
Wistia is a software company that helps businesses build their brands with video. Their mission is to make business more human, and part of that includes a focus on diversity, equity, and inclusion. In 2019, when Georgia passed legislation restricting access to abortion, Wistia spoke up as a company in support of reproductive rights and abortion.…
“I am proud that many of my primary care colleagues took a stance against the NC HB 918, favoring more equitable care and working to eliminate barriers for marginalized communities. This bill threatened to dismantle the foundational family unit, disproportionately affecting families afflicted by systemic racism and poverty. Taking a stance against HB 918 communicates…
In 2018, the FDA approved a one-year contraceptive vaginal ring. It’s a flexible silicone ring that slowly releases segesterone acetate and ethinyl estradiol. The brand name is Annovera. The label instructs patients to insert the ring for three weeks and remove it for one week, repeating the cycle a total of thirteen times before starting…
Your gift allows us to train and support health care providers across the United States so they can offer patients compassionate and comprehensive care.
Aug 14
